21 November 2019

The grant application called "aiREAD – Accurate and Intelligent Reading for EArlier breast cancer Detection” by project leader Ioannis Sechopoulos, has been selected for funding under the NWO TTW – KWF Kankerbestrijding – Top Sector LSH Partnership “Technology for Oncology II”.

By developing and applying new artificial intelligence methods, and advancing our knowledge on human visual perception of medical images, the investigators will improve how radiologists read breast cancer screening mammograms. Optimal reading of the screening mammograms will result in earlier detection of breast cancer, fewer healthy women recalled due to false alarms, and savings in the costs of healthcare.

Lead by Ioannis Sechopoulos, the project team consists of Jonas Teuwen, from the Department of Radiology and Nuclear Medicine, Mireille Broeders (Department for Health Evidence and the Dutch Expert Centre for Screening, LRCB), Ruud Pijnappel (UMC Utrecht and LRCB), Lucien Duijm (Canisius Wilhelmina Hospital and LRCB), and Craig Abbey and Miguel Eckstein (both from University of California, Santa Barbara, USA).

Read more on the NWO website (in Dutch).

Ioannis Sechopoulos is a member of theme Women's cancers and the LRCB, and leader of the AXTI laboratory.

Related news items


Jong KNCV organizes a Pitch competition for PhD candidates

13 August 2020

Are you a PhD candidate and would you like to win 500 euros with a pitch about your research? Young KNCV gives you that chance! During the KNCV Chemistry 2020 Evening on October 8th.

read more

Collective invasion induced by autocrine purinergic loop through connexin-43 hemichannels

13 August 2020

Peter Friedl and Paul Span show in Journal of Cell Biology that breastcancer cells release purines into the extracellular space via connexin-43 hemichannels to control collective invasion.

read more

TP53 allelic state is critical for diagnostic and prognostic precision in blood cancer

12 August 2020

An international study, in which Joop Jansen participated, shows that a double mutaton in TP53 gene deteriotes the prognosis of a rare form of blood cancer. If there is only one mutation or no mutation, then the prognosis is better.

read more

BCG vaccine is safe with no increased risk of COVID-19 symptoms says Mihai Netea

11 August 2020

The BCG vaccine has a general stimulatory effect on the immune system and is therefore effective against multiple infectious diseases - possibly also against COVID-19.

read more

650,000 Euro funding for research into the phasing out of medication for leukaemia patients

30 July 2020

With a 650,000 euro funding from ZonMw, researchers from the Haematology and Pharmacy departments can develop a medication phasing out strategy for patients with chronic myeloid leukaemia. This strategy will be tested in practice.

read more

Increased role of patients after bowel cancer treatment

30 July 2020

Approximately 14,000 patients get colorectal cancer every year. Almost all patients are operated on and monitored afterwards (follow-up). In 2019 Radboudumc started a new approach to follow-up research after the treatment of stage II/III colorectal cancer.

read more